The observed disconnection of BCAR1 and EREG in late-stage left-sided primary tumors and metastases points to the involvement of other factors/mechanisms influencing their expression, such as methylation changes within the EREG promoter [40] or altered cross-signaling through interactions with the tumor microenvironment [41]. The gene discussed is EREG; the disease is neoplasm.